Children's Healthcare of Atlanta
Pediatric health care system
Based in GA
🤖
AI Overview
With $1.4M in lobbying spend across 27 quarterly filings, Children's Healthcare of Atlanta is a significant lobbying presence.
$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
8
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $100K |
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $150K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $150K |
| 2025 | $150K |
Lobbying Firms
ARENTFOX SCHIFF LLP
What They Lobby For
- Autism research programs and autism intervention programs generally Department of Education special education programs regarding autism Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 6470 and S. 3158 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019), regarding National Institutes of Health funding level, Children's Hospital Graduate Medical Education program, sickle cell disease, and other programs related to pediatric health care H.R. 6157 (Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019), Division B, Title II regarding HHS appropriations
- Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations Section 340B Drug Pricing Program, including H.R. 4710 (340B PAUSE Act), all provisions, H.R. 5598 (340B Optimization Act), all provisions, and H.R. 6240 (Drug Discount Accountability Act), all provisions H.R. 5385 (Dr. Benjy Frances Brooks Children's Hospital GME Support Reauthorization Act of 2018), all provisions S. 2597 (Children's Hospital GME Support Reauthorization Act of 2018), all provisions Sickle cell disease research funding generally Drug pricing reforms generally Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities H.R. 6560 (ChiPACC Act of 2018), all provisions Department of Homeland Security rulemaking regarding public charge rule and Medicaid program implications S. 3429 (Neonatal Abstinence Intervention Act), all provisions H.R. 2410 (Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017), all provisions S. 2465 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018), all provisions H.R. 6 (SUPPORT for Patients and Communities Act), Section 1004 regarding Medicaid drug review and utilization H.R. 6458 (National Organ Transplant Act Amendments of 2018), all provisions H.R. 3325 (ACE Kids Act), all provisions S. 428 (ACE Kids Act of 2017), all provisions
- Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations S. 3770 (Medicaid Drug Decisions Transparency Act), all provisions Section 340B Drug Pricing Program, including H.R. 4710 (340B PAUSE Act), all provisions, H.R. 5598 (340B Optimization Act), all provisions, and H.R. 6240 (Drug Discount Accountability Act), all provisions Sickle cell disease research funding generally Drug pricing reforms generally Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities Department of Homeland Security rulemaking regarding public charge rule and Medicaid program implications S. 3429 (Neonatal Abstinence Intervention Act), all provisions H.R. 2410 (Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017), all provisions S. 2465 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018), all provisions H.R. 3325 (ACE Kids Act), all provisions S. 428 (ACE Kids Act of 2017), all provisions H.R. 1676 (Palliative Care and Hospice Education and Training Act), all provisions Organ transplant policy generally, including liver transplant distribution methodology H.R. 7217 (Improving Medicaid Programs and Opportunities for Eligible Beneficiaries Act - IMPROVE Act), Title I, regarding coordinated care
- Autism research programs and autism intervention programs generally Department of Education special education programs regarding autism Department of Health and Human Services programs regarding autism and sickle cell disease research
- Autism research programs and autism intervention programs generally Department of Education special education programs regarding autism Department of Health and Human Services programs regarding autism and sickle cell disease research H.R.1058 and S.427 (Autism CARES Act of 2019), all provisions FY 2020 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Childrens Hospital Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care H.J.Res. 31 (Consolidated Appropriations Act, 2019), regarding federal funding generally
- Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities Organ transplant policy generally, including liver transplant distribution methodology Legislation regarding hospital billing practices H.R.1839 (Medicaid Services Investment and Accountability Act of 2019), Section 3, regarding Medicaid reimbursement for medically complex children Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) programs H.R. 2076 and S.1009 (Early Detection to Stop Infant Abuse and Prevent Fatalities Act), all provisions
- Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities Organ transplant policy generally, including liver transplant distribution methodology Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) programs H.R. 2076 and S. 1009 (Early Detection to Stop Infant Abuse and Prevent Fatalities Act), all provisions S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices
- Autism research programs and autism intervention programs generally Department of Education special education programs regarding autism Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 1058 and S. 427 (Autism CARES Act of 2019), all provisions H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020), Division A, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care
- Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally, including H.R. 3 (Lower Drug Costs Now Act of 2019), all provisions Department of Justice implementation of grant program for missing individuals with autism and developmental disabilities Organ transplant policy generally, including liver transplant distribution methodology Reauthorization of Child Abuse Prevention And Treatment Act (CAPTA) programs S. 1895 (Lower Health Care Costs Act), Title I, regarding hospital billing practices H.R. 2328 (REACH Act), Title IV, regarding hospital billing practices Department of Homeland Security "public charge" rule regarding access to Medicaid benefits Implementation of Children's Hospital Graduate Medical Education program
- Autism research programs and autism intervention programs generally Department of Education special education programs regarding autism Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 1058 and S. 427 (Autism CARES Act of 2019), all provisions H.R. 2740 (Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020), Division A, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education program, sickle cell disease research, and other programs related to pediatric health care H.R. 4378 (Continuing Appropriations Act, 2020, and Health Extenders Act of 2019), Division A, regarding HHS appropriations
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.